Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 J+Pediatr+Pharmacol+Ther 2003 ; 8 (1): 40-5 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Magnesium Sulfate for Severe Acute Asthma in Children #MMPMID23300395
Kelly HW
J Pediatr Pharmacol Ther 2003[Jan]; 8 (1): 40-5 PMID23300395show ga
Magnesium is an abundant intracellular cation that has been used for years in the treatment of hyper-tension and seizures associated with eclampsia of pregnancy as well as used as a tocolytic agent.1 Over sixty years ago, Haury showed that magnesium sulfate (MgSO4) could produce bronchodilation in asthmatics.2 However, interest in magnesium sulfate as a potential therapy for acute asthma surfaced in the late 1980s following a series of studies demonstrating that magnesium produced dose-dependent bronchodilation. The precise mechanism by which magnesium produces smooth muscle relaxation is not known, but it is thought to act by enhancing calcium uptake in the sarcoplasmic reticulum3 and/or as a calcium antagonist.4 In addition, magnesium is a cofactor regulating a number of enzymatic and cellular activities in the body, including adenyl cyclase and sodium-potassium ATP-ase, potentially enhancing the effects of ?2-agonists.5 Other potential beneficial mechanisms in asthma include inhibition of acetylcholine release from cholinergic nerves6 and reduction of histamine release from mast cells.7It is not clear whether magnesium acts as a functional antagonist to bronchoconstriction like the ?2-agonists and theophylline or a specific antagonist like anticholinergics and antihistamines. Studies showing attenuation of the bronchoconstriction from histamine and methacholine would suggest functional antagonism.8,9 Some suggest that the response to intravenous magnesium sulfate is dependent upon achieving serum magnesium concentrations of 4?6 mg/dL (1.6?2.4 mmol/L).10 These values are similar to those that are employed to achieve tocolysis (4?8 mg/dL) and about one half those associated with severe toxicity of respiratory failure, cardiac arrhythmias and death (12?15 mg/ dL).1 It should be pointed out that studies have not reported lower magnesium concentrations in asthmatics than controls although one study reported correlation with bronchial hyperresponsiveness and intracellular magnesium concentrations in asthmatics. 11?13 Thus, it is unlikely that the bronchodilator response to magnesium is a result of restoring normal homeostasis but most likely a function of its direct antagonistic effects on intracellular calcium activity.
free
free
free
J+Pediatr+Pharmacol+Ther 2003 ; 8 (1): 40-5
